02157 LEPU BIO-B
- 2.720
- -0.130-4.56%
LEPU BIO-B News
LEPU BIO-B: CONTINUING CONNECTED TRANSACTIONCDMO SERVICES FRAMEWORK AGREEMENT
LEPU BIO-B: ANNOUNCEMENT OFPROPOSED CHANGE OF AUDITOR
LEPU BIO-B: CONTINUING CONNECTED TRANSACTIONNEW PROCUREMENT FRAMEWORK AGREEMENT
LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024
LEPU BIO-B: VOLUNTARY ANNOUNCEMENTACCEPTANCE OF THE NEW DRUG APPLICATION AND PRIORITYREVIEW GRANTED BY NMPA TOMRG003 FOR THE TREATMENT OF R/M NPC
LEPU BIO-B: 2024 Interim Report
LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
LEPU BIO-B: ARTICLES OF ASSOCIATION
LEPU BIO-B: AMENDMENTS TO THE ARTICLES OF ASSOCIATION
LEPU BIO-B: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED JUNE 30, 2024
LEPU BIO-B: NOTICE OF BOARD MEETING
LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
LEPU BIO-B: VOLUNTARY ANNOUNCEMENTBREAKTHROUGH THERAPY DESIGNATION GRANTEDBY THE FDA TO MRG003 FOR THE TREATMENT OF R/M NPC
LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
LEPU BIO-B: POLL RESULTS OF THE 2023 ANNUAL GENERAL MEETINGHELD ON JUNE 19, 2024
LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
LEPU BIO-B: Proxy Form for the Annual General Meeting to be held on June 19 2024
LEPU BIO-B: (1) 2023 REPORT OF THE BOARD OF DIRECTORS(2) 2023 REPORT OF THE BOARD OF SUPERVISORS(3) 2023 ANNUAL REPORT(4) 2023 FINANCIAL ACCOUNTS REPORT(5) 2024 FINANCIAL BUDGET(6) 2023 ANNUAL PROFIT DISTRIBUTION PLAN(7) RE-APPOINTMENT OF AUDITOR(8) GENERAL MAN
LEPU BIO-B: NOTICE OF THE 2023 ANNUAL GENERAL MEETING
No Data
